Page 25 - Ebitda And Aisc Guidance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ebitda and aisc guidance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ebitda And Aisc Guidance Today - Breaking & Trending Today

Net Profit: Tata Motors consolidated net profit at Rs 3800 crore

Tata Motors clocked a consolidated net profit of around Rs 3800 crore in Q2FY24 even as its revenue jumped 32% to Rs 105128 crore. The company’s EBITD ....

Tamil Nadu , Tata Motors , Net Profit , Consolidated Net Profit , Auto Verticals ,

Update: CVS, November 1

CVS Health (CVS) reported Q3 results this morning. Specifically, revenues for the period grew 10.6% from the prior year to $89.76 billion and came in $1.48 billion [.] ....

Cvs Health ,

JK Tyre: JK Tyre & Industries plans Rs 1025 crore investment to expand production capacity

The company - which currently is utilising 95% of its available capacity of 155.11 lakh tyres per annum- plans to expand capacity by about 20% by October 2025. The expansion is proposed to be funded by way of equity/internal accruals and debt. Raghupati Singhania, Chairman & Managing Director, JK Tyre & Industries told ET, the company is planning fresh investments to increase capacity amid robust demand in the local market. ....

Raghupati Singhania , Jk Tyre Industries , Managing Director , Industries Wednesday , Jk Tyre , Tyre Industries , Tyre Demand , Tyre Production Capacity , Jk Tyre Amp Industries ,

Supplementary Review: Avanos Medical (AVNS), November 1, 2023

Q3 net sales from continuing operations fell 0.6% year-over-year to $171.3 million. Sales from its Digestive Health franchise grew by 10.6% to $95.0 million on [.] ....

Digestive Health , Supplementary Review Avanos Medical ,

net profit: Mankind Pharma Q2 Results: Net profit jumps 21% to Rs 511 crore, led by one-off US export opportunities

Revenue rose 11.6% YoY to Rs 2,708 in Q2FY24. The earnings before interest, tax, depreciation and amortization (EBITDA) grew 15.4% YoY to Rs 686 crore. The EBITDA margin rose 80 basis points YoY to 25.3%. ....

Mankind Pharma , Net Profit , Us Export , Q2 Results ,